2 EIAP Reference Letter

OMB Burden Statement
OMB No.: 0925-0761
Expiration Date: 07/31/2025
Collection of this information is authorized by The Public Health Service Act, Section 411 (42 USC 285a). Rights of
study participants are protected by The Privacy Act of 1974. Participation is voluntary, and there are no penalties for
not participating or withdrawing from the study at any time. Refusal to participate will not affect your benefits in any
way. The information collected in this study will be kept private to the extent provided by law. Names and other
identifiers will not appear in any report of the study. Information provided will be combined for all study participants
and reported as summaries. You are being asked to complete this form so that we can process your application for
the Intramural Continuing Umbrella of Research Experiences (iCURE) program.
Public reporting burden for this collection of information is estimated to average 30 minutes per response, including
the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is
not required to respond to, a collection of information unless it displays a currently valid OMB control
number. Send comments regarding this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC
7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0761). Do not return the completed form to this address.

Dear Dr. [reference]:
Dr. [applicant name] has applied to the NCI Early Investigator Advancement Program (EIAP) and named
you as a reference. The EIAP aims to promote the transition of extramural and intramural junior
investigators to independent investigators while furthering NCI’s commitment to diversity. The EIAP will
help enhance professional skills, guide construction of a R01 grant application, provide a mentoring and
peer network and build a diverse community of emerging independent cancer research investigators.
Thank you for providing a letter of recommendation. In your letter, please include:
•
•
•
•

Applicant’s full name, in bold.
Comments on applicant’s motivation, commitment, and qualifications toward scientific research.
Comments on applicant’s potential contribution to enhancing diversity in the biomedical and
cancer research workforce.
An assessment of applicant’s strengths and weaknesses, how you feel this program might help the
applicant, and whether you feel applicant would be a competitive candidate for the EIAP and is
ready to be an R01-funded investigator.

Please submit by email your letter of recommendation as a PDF document by [insert date, two weeks
from date of email] to [email protected], addressed to:
Alison Lin, PhD
EIAP
Center to Reduce Cancer Health Disparities (CRCHD)
National Cancer Institute Shady Grove Campus
9609 Medical Center Drive
Rockville, MD 20850
Additional information about EIAP is available at https://www.cancer.gov/aboutnci/organization/crchd/diversity-training/EIAP. Please contact us with any questions about this request or
EIAP. We look forward to your recommendation letter.
Best regards,